Avrobio avrobio.com


Public list: Genomics (520) Pharma Startups (4733) Rare Diseases (131)

Avrobio (NASDAQ: AVRO) is a provider of lentiviral-based gene therapies. The company is focused on the development of its programs in Fabry disease and acute myeloid leukemia (AML), while actively building a pipeline of therapies to treat other rare diseases, including solid and liquid cancers.

Avrobio (NASDAQ: AVRO) is a provider of lentiviral-based gene therapies. The company is focused on the development of its programs in Fabry disease and acute myeloid leukemia (AML), while actively building a pipeline of therapies to treat other rare ...Show all

Company (IPO / Went public)

Phone: 617-914-8420

Fax:

One Kendall Square
Building 300, Suite 201
Cambridge, 02139
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Avrobio $184.7M Jun 21, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Avrobio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors

Competitors

Company Status Description Investors

Patents

Title Application Date Patent Date Status
(Patent / Application)